209 related articles for article (PubMed ID: 28811081)
21. DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors.
Park JK; Paik WH; Lee K; Ryu JK; Lee SH; Kim YT
Oncotarget; 2017 Jul; 8(30):49796-49806. PubMed ID: 28591701
[TBL] [Abstract][Full Text] [Related]
22. Role of Combined 68Ga-DOTATOC and 18F-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors: Implications for Managing Surgical Decisions.
Cingarlini S; Ortolani S; Salgarello M; Butturini G; Malpaga A; Malfatti V; DʼOnofrio M; Davì MV; Vallerio P; Ruzzenente A; Capelli P; Citton E; Grego E; Trentin C; De Robertis R; Scarpa A; Bassi C; Tortora G
Pancreas; 2017 Jan; 46(1):42-47. PubMed ID: 27906872
[TBL] [Abstract][Full Text] [Related]
23. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: MEN1-related pancreatic NETs: identification of unmet clinical needs and future directives.
Pieterman CRC; Sadowski SM; Maxwell JE; Katz MHG; Lines KE; Heaphy CM; Tirosh A; Blau JE; Perrier ND; Lewis MA; Metzcar JP; Halperin DM; Thakker RV; Valk GD
Endocr Relat Cancer; 2020 Aug; 27(8):T9-T25. PubMed ID: 32069215
[TBL] [Abstract][Full Text] [Related]
24. Cystic pancreatic neuroendocrine tumors: a clinicopathologic study.
Singhi AD; Chu LC; Tatsas AD; Shi C; Ellison TA; Fishman EK; Kawamoto S; Schulick RD; Wolfgang CL; Hruban RH; Edil BH
Am J Surg Pathol; 2012 Nov; 36(11):1666-73. PubMed ID: 23073325
[TBL] [Abstract][Full Text] [Related]
25. Management of pancreatic endocrine tumors in multiple endocrine neoplasia type 1.
Kouvaraki MA; Shapiro SE; Cote GJ; Lee JE; Yao JC; Waguespack SG; Gagel RF; Evans DB; Perrier ND
World J Surg; 2006 May; 30(5):643-53. PubMed ID: 16680581
[TBL] [Abstract][Full Text] [Related]
26. Impact of Delay in Diagnosis in Outcomes in MEN1: Results From the Dutch MEN1 Study Group.
van Leeuwaarde RS; van Nesselrooij BP; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Vriens MR; de Laat JM; Pieterman CR; Valk GD
J Clin Endocrinol Metab; 2016 Mar; 101(3):1159-65. PubMed ID: 26751192
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological characteristics and risk factors for recurrence of well-differentiated pancreatic neuroendocrine tumors after radical surgery: a case-control study.
Zhang P; Li YL; Qiu XD; Luo J; Shi YF; Sun YL; Su F; Qi ZR; Tan HY
World J Surg Oncol; 2019 Apr; 17(1):66. PubMed ID: 30975157
[TBL] [Abstract][Full Text] [Related]
28. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
[TBL] [Abstract][Full Text] [Related]
29. Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification.
Yang Z; Tang LH; Klimstra DS
Am J Surg Pathol; 2011 Jun; 35(6):853-60. PubMed ID: 21566513
[TBL] [Abstract][Full Text] [Related]
30. Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form.
Gibril F; Venzon DJ; Ojeaburu JV; Bashir S; Jensen RT
J Clin Endocrinol Metab; 2001 Nov; 86(11):5282-93. PubMed ID: 11701693
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
Gaztambide S; Vazquez F; Castaño L
Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
[TBL] [Abstract][Full Text] [Related]
32. No Association of Blood Type O With Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.
Nell S; van Leeuwaarde RS; Pieterman CR; de Laat JM; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IH; Vriens MR; Valk GD
J Clin Endocrinol Metab; 2015 Oct; 100(10):3850-5. PubMed ID: 26247473
[TBL] [Abstract][Full Text] [Related]
33. EUS detection of pancreatic endocrine tumors in asymptomatic patients with type 1 multiple endocrine neoplasia.
Wamsteker EJ; Gauger PG; Thompson NW; Scheiman JM
Gastrointest Endosc; 2003 Oct; 58(4):531-5. PubMed ID: 14520285
[TBL] [Abstract][Full Text] [Related]
34. Value of diffusion-weighted magnetic resonance imaging in predicting World Health Organization grade in G1/G2 pancreatic neuroendocrine tumors.
Guo C; Zhuge X; Chen X; Wang Z; Xiao W; Wang Q
Oncol Lett; 2017 Jun; 13(6):4141-4146. PubMed ID: 28599415
[TBL] [Abstract][Full Text] [Related]
35. Long-Term Natural Course of Small Nonfunctional Pancreatic Neuroendocrine Tumors in MEN1-Results From the Dutch MEN1 Study Group.
Pieterman CRC; de Laat JM; Twisk JWR; van Leeuwaarde RS; de Herder WW; Dreijerink KMA; Hermus ARMM; Dekkers OM; van der Horst-Schrivers ANA; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IHM; Vriens MR; Valk GD
J Clin Endocrinol Metab; 2017 Oct; 102(10):3795-3805. PubMed ID: 28938468
[TBL] [Abstract][Full Text] [Related]
36. Role of diffusion-weighted MR imaging in predicting the grade of nonfunctional pancreatic neuroendocrine tumors.
Kulali F; Semiz-Oysu A; Demir M; Segmen-Yilmaz M; Bukte Y
Diagn Interv Imaging; 2018 May; 99(5):301-309. PubMed ID: 29258825
[TBL] [Abstract][Full Text] [Related]
37. Neuroendocrine tumors of the pancreas: current concepts and controversies.
Reid MD; Balci S; Saka B; Adsay NV
Endocr Pathol; 2014 Mar; 25(1):65-79. PubMed ID: 24430597
[TBL] [Abstract][Full Text] [Related]
38. Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs).
Partelli S; Gaujoux S; Boninsegna L; Cherif R; Crippa S; Couvelard A; Scarpa A; Ruszniewski P; Sauvanet A; Falconi M
JAMA Surg; 2013 Oct; 148(10):932-9. PubMed ID: 23986355
[TBL] [Abstract][Full Text] [Related]
39. Metastasectomy of neuroendocrine tumors in patients with multiple endocrine neoplasia type 1.
Dy BM; Que FG; Thompson GB; Young WF; Rowse P; Strajina V; Richards ML
Am J Surg; 2014 Dec; 208(6):1047-53; discussion 1052-3. PubMed ID: 25440487
[TBL] [Abstract][Full Text] [Related]
40. Prospective endoscopic ultrasonographic evaluation of the frequency of nonfunctioning pancreaticoduodenal endocrine tumors in patients with multiple endocrine neoplasia type 1.
Thomas-Marques L; Murat A; Delemer B; Penfornis A; Cardot-Bauters C; Baudin E; Niccoli-Sire P; Levoir D; Choplin Hdu B; Chabre O; Jovenin N; Cadiot G;
Am J Gastroenterol; 2006 Feb; 101(2):266-73. PubMed ID: 16454829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
